// App-Quantinova.ai

Mo1773 : Variation in the Treatment of New Onset Pediatric IBD Among Phenotypically Similar Patient Subgroups in Canada: A Cross-Sectional Analysis of the Canadian Children IBD Network Inception Cohort

Researchers

Presenter

  • David R. Mack

Principal Investigators

  • Hien q. Huynh

  • Jeffrey Critch

  • Peter Church

  • Eric Benchimol

  • Matthew Carroll

  • Eytan Wine

  • Mohsin Rashid

  • Johan E. Van Limbergen

  • Anne M. Griffiths

  • Anthony R. Otley

  • Jennifer de Bruyn

  • Colette Deslandres

  • Wael El-Matary

  • Kevan Jacobson

  • Mary Sherlock

  • Kevin Bax

  • Ernest G. Seidman

Medical Centers

  • CHU Sainte-Justine, Montreal, QC, Canada

  • Div. GI and Nutrition, Dept of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

  • Stollery Children's Hospital, University of Alberta Hospital, Edmonton, AB, Canada

  • British Columbia Childrens Hospital & University of British Columbia, Vancouver, Canada

  • Research Institute McGill University Health Center, Montreal, Quebec, Canada

  • Div Paed GI and Nutrition, McMaster University, Hamilton, Ontario, Canada

  • Alberta Childrens Hospital, Calgary, AB, Canada

  • CHEO IBD Centre and Research Institute and Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada

  • Div Paed GI, Children's Hospital of Western Ontario, University of Western Ontario, London, Ontario, Canada

  • Div Paed GI, Janeway Children's Health and Rehabilitation Centre, Memorial University Of Newfoundland, St John's, Newfoundland, Canada

  • Division of GI & Nutrition, IWK Health Centre & Dalhousie University, Halifax, Nova Scotia, Canada

  • The Childrens Hospital Research Institute of Manitoba, Winnipeg, MB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Ulcerative colitis

  • Inflammatory bowel disease unclassified

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Mesalamine

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim